Tianli International Holdings Limited (01773) spent HK$232,000 on December 19th to repurchase 100,000 shares.
Tianli International Holdings (01773) announced that it will repurchase 100,000 shares at a cost of HKD 232,000 on December 19, 2025.
TIANLI INT HLDG (01773) announced that on December 19, 2025, it spent HK$232,000 to repurchase 100,000 shares.
Related Articles
CHINA LESSO (02128) and Guangdong Liansu Electric have signed a parts supply agreement.
Jiangsu Hengrui Pharmaceuticals (01276): SHR-2906 Injection Obtains Drug Clinical Trial Approval Letter.
Jiangsu Hengrui Pharmaceuticals (01276): SHR-9539 injection, HRS-3738 tablets received the approval notice for drug clinical trials.
CHINA LESSO (02128) and Guangdong Liansu Electric have signed a parts supply agreement.
Jiangsu Hengrui Pharmaceuticals (01276): SHR-2906 Injection Obtains Drug Clinical Trial Approval Letter.
Jiangsu Hengrui Pharmaceuticals (01276): SHR-9539 injection, HRS-3738 tablets received the approval notice for drug clinical trials.
